Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Genfit Ends Phase 3 Trial of NASH Drug Elanfibranor After Finding No Benefit July 22, 2020 Ireland’s NSAI Becomes 11th Notified Body Under EU MDR February 24, 2020 FDA Approves Three Drugs Through Rx-to-OTC Switch Process February 24, 2020
